drugset / Trial / NCT07814404

A Study to Assess the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB161734 in Healthy Male Participants

NCT07814404 ↗

Phase 1 Not yet recruiting 10 enrolled Incyte Corporation
NaSingle-groupOpen-labelTreatment

Summary

This study is conducted to assess the mass balance, pharmacokinetics, and metabolite profiles of a single oral dose of \[14C\]-INCB161734 in healthy male participants.

Timeline

Start
2026-09-18
Primary completion
2026-10-15
Completion
2026-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject INCB161734 Unknown — Oral

Indications

No indication recorded.